Keywords: exelixis, deal, b-ms, worth, over, 240m, drug

Exelixis in deal with B-MS worth over $240M

Article | 22 December 2008

Print This

Drug major Bristol-Myers Squibb has entered a global collaboration with fellow USA-based Exelixis worth at least $240.0 million to the latter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in